Thalassemia and sickle cell disease (SCD) testing often requires broad variant coverage, confident detection of common deletions, and results you can report without added complexity. In this webinar, we will introduce Devyser Thalassemia v2 (CE-IVDR), our recently launched NGS assay for genetic testing of thalassemia and SCD, and walk you through the product features and how it can simplify your workflow.

Why you should watch this webinar:

• Learn about comprehensive detection of relevant variant types, including SNVs, indels, CNVs, and complex deletions
• Get an overview of the streamlined workflow, same-day library preparation and minimal hands-on time
• Discover the improved user experience and new features of Amplicon Suite for Thalassemia v2 analysis
• Discover how Devyser Thalassemia v2, together with the option to lease compatible Illumina sequencing instruments, can help laboratories overcome infrastructure barriers and implement NGS testing in-house.

Can’t attend live?
Everyone who registers will receive access to the on-demand recording after the webinar.